BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17063269)

  • 21. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
    Purmonen S; Manninen T; Pennanen P; Ylikomi T
    Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oestrogens, progestins and breast proliferation.
    Thijssen JH
    Zentralbl Gynakol; 1997; 119 Suppl 2():43-7. PubMed ID: 9361394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progesterone and breast cancer].
    Mansueto G; Mistretta V; Angeletti F; Trento LK; Angelozzi D; Bracaglia M; Pagliarella MR; Di Muccio L
    Recenti Prog Med; 2006; 97(7-8):376-80. PubMed ID: 16913172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
    Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
    [No Abstract]   [Full Text] [Related]  

  • 25. Progesterone and breast cancer.
    Lange CA; Yee D
    Womens Health (Lond); 2008 Mar; 4(2):151-62. PubMed ID: 19072517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Directly comparing routes of administration and types of hormone therapy on risk markers for breast cancer.
    Pru JK
    Menopause; 2007; 14(4):611. PubMed ID: 17471109
    [No Abstract]   [Full Text] [Related]  

  • 27. Hormone replacement and the risk of breast cancer in Turner's syndrome.
    Bösze P; Tóth A; Török M
    N Engl J Med; 2006 Dec; 355(24):2599-600. PubMed ID: 17167149
    [No Abstract]   [Full Text] [Related]  

  • 28. Hormone therapy and breast cancer risk.
    Foidart JM; Desreux J; Pintiaux A; Gompel A
    Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
    Ribot C; Trémollieres F
    Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M; Simoncini T; Fuller S; Genazzani AR
    Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progestogen use in women approaching the menopause and breast cancer risk.
    Campagnoli C; Ambroggio S; Lotano MR; Peris C
    Maturitas; 2009 Apr; 62(4):338-42. PubMed ID: 19118958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormone replacement therapy in patients after breast cancer].
    Köninger A; Kümmel S; Kimmig R
    MMW Fortschr Med; 2008 Oct; 150(43):32-4. PubMed ID: 19025144
    [No Abstract]   [Full Text] [Related]  

  • 33. [The Danish Nurse Cohort Study 1993-2003].
    Hundrup YA; Obel EB; Rasmussen NK; Grønbaek M
    Ugeskr Laeger; 2004 Apr; 166(15-16):1451-4. PubMed ID: 15146817
    [No Abstract]   [Full Text] [Related]  

  • 34. [Estrogens, progesterones and the mammary gland].
    Heikinheimo O
    Duodecim; 2005; 121(5):525-32. PubMed ID: 15839154
    [No Abstract]   [Full Text] [Related]  

  • 35. Is combined estrogen/progestogen hormone therapy worth the risk?
    Sturdee DW; MacLennan AH
    Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormone replacement therapy - where to from here? (with response from Sandra Coney).
    Fenton A
    N Z Med J; 2002 Sep; 115(1161):U163; discussion U163. PubMed ID: 12386670
    [No Abstract]   [Full Text] [Related]  

  • 37. Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.
    Chlebowski RT; Prentice RL
    J Natl Cancer Inst; 2008 Oct; 100(19):1341-3. PubMed ID: 18812547
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hormone therapy and cancer 2].
    Halse SA
    Ugeskr Laeger; 2004 Mar; 166(12):1133. PubMed ID: 15067781
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hormone therapy and cancer].
    Halse SA
    Ugeskr Laeger; 2004 Feb; 166(8):719; author reply 719-21. PubMed ID: 15042826
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.